2011Zhōnghuá yàoxué zázhìRequires access

Bioequivalence and Pharmacokinetics Study of Losartan Potassium Tablets in Healthy Volunteers by LC-MS/MS Method

Meng Wang

Open publisher page 0 citations

Abstract

OBJECTIVE To develope an LC-MS/MS method for the determination of losartan in human plasma,and to evaluate the pharmacokinetics and bioequivalence of losartan tablets in healthy volunteers.METHODS A single oral dose of reference and test tablets was given to 20 healthy male volunteers according to a randomized crossover design.Plasma concentrations were determined by LC-MS/MS after deproteinization by methanol.The pharmacokinetic parameters were calculated by DAS2.0.RESULTS The main pharmacokinetic parameters of losartan test and reference preparations were as follows: ρmax(222±131) and(226±166) μg·L-1,tmax(1.28±0.64) and(1.45±0.70) h,t1/2(1.91±0.32) and(1.90±0.37) h,AUC0-12 h(450±191) and(446±227) μg·h·L-1,respectively.The relative bioavailability of the test preparation was(104.0 ±14.3)%.CONCLUSION The LC-MS/MS method is proved to be accurate,sensitive and convenient;the test tablets are bioequivalent to the reference tablets.

About this research paper

What this paper is about

OBJECTIVE To develope an LC-MS/MS method for the determination of losartan in human plasma,and to evaluate the pharmacokinetics and bioequivalence of losartan tablets in healthy volunteers.METHODS A single oral dose of reference and test tablets was given to 20 healthy male volunteers according to a randomized crossover design.Plasma concentrations were determined by LC-MS/MS after deproteinization by methanol.The pharmacokinetic parameters were calculated by DAS2.0.RESULTS The main pharmacokinetic parameters of losartan test and reference preparations were as follows: ρmax(222±131) and(226±166) μg·L-1,tmax(1.28±0.64) and(1.45±0.70) h,t1/2(1.91±0.32) and(1.90±0.37) h,AUC0-12 h(450±191) and(446±227) μg·h·L-1,respectively.The relative bioavailability of the test preparation was(104.0 ±14.3)%.CONCLUSION The LC-MS/MS method is proved to be accurate,sensitive and convenient;the test tablets are bioequivalent to the reference tablets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To develope an LC-MS/MS method for the determination of losartan in human plasma,and to evaluate the pharmacokinetics and bioequivalence of losartan tablets in healthy volunteers.METHODS A single oral dose of reference and test tablets was given to 20 healthy male volunteers according to a randomized crossover design.Plasma concentrations were determined by LC-MS/MS after deproteinization by methanol.The pharmacokinetic parameters were calculated by DAS2.0.RESULTS The main pharmacokinetic parameters of losartan test and reference preparations were as follows: ρmax(222±131) and(226±166) μg·L-1,tmax(1.28±0.64) and(1.45±0.70) h,t1/2(1.91±0.32) and(1.90±0.37) h,AUC0-12 h(450±191) and(446±227) μg·h·L-1,respectively.The relative bioavailability of the test preparation was(104.0 ±14.3)%.CONCLUSION The LC-MS/MS method is proved to be accurate,sensitive and convenient;the test tablets are bioequivalent to the reference tablets.

Key concepts: Bioequivalence, Pharmacokinetics, Losartan Potassium, Bioavailability, Losartan, Crossover study, Chromatography, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence and Pharmacokinetics Study of Losartan Potassium Tablets in Healthy Volunteers by LC-MS/MS Method — Research Paper | ScholarLens